latest update:
[RxAtlas]

drug summary · 2 NDC codes

Vyvanse 60 mg/1

lisdexamfetamine dimesylate

HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status NDA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.

dataset id 143148NDC codes 2application NDA021977RxCUI —

Facts

Field definitions, types, and provenance rules are in the data dictionary.

generic namelisdexamfetamine dimesylate
active ingredientsLISDEXAMFETAMINE DIMESYLATE
dosage formCAPSULE
routeORAL
strength60 mg/1
marketing statusNDA
DEA scheduleCII
application numberNDA021977
ATC codenot reported
RxCUInot reported
manufacturerTakeda Pharmaceuticals America, Inc.
product typeHUMAN PRESCRIPTION DRUG
pharmacologic classCentral Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]

NDC codes

2 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.

NDCPackage description
59417-106—
59417010610—

Other lisdexamfetamine dimesylate products

25 other products in the current release publish the same generic name. Strength, dosage form, and labeler are what distinguish them.

13 more are listed in the drug product index.

Work with this record

  • Field definitions

    Types, scope, and provenance rules for every exported field.

  • REST API

    Query the same gate-backed records programmatically.

  • Evaluation sample

    Download a bounded slice before buying.

  • $29 API Pass

    Seven days of REST and MCP access to the full catalogue; credited toward the licence.